Congenital malformations of eye, ear, face and neck

Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 Q10-Q18
  • Cause of death: ICD-10 Q10-Q18

2 out of 7 registries used, show all original rules.

2740

4. Check minimum number of events

None

2740

5. Include endpoints

2740

6. Filter based on genotype QC (FinnGen only)

2740

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q
Name in latin
Malformationes congenitae oculorum, aurium, faciei et colli

Similar endpoints

List of similar endpoints to Congenital malformations of eye, ear, face and neck based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 42386 21671 20654
Only index persons 33417 17407 16010
Unadjusted period prevalence (%)
Whole population 0.60 0.62 0.58
Only index persons 0.63 0.64 0.61
Median age at first event (years)
Whole population 6.75 7.53 5.86
Only index persons 11.62 13.48 9.60

-FinnGen-

Key figures

All Female Male
Number of individuals 2740 1739 1001
Unadjusted period prevalence (%) 0.54 0.59 0.44
Median age at first event (years) 31.42 27.92 37.51

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2489
Matched controls
24888
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ENB40
NOMESCO Finland
Excision of branchial cyst or fistula
1441.4
323.0
369
*
DAD30
NOMESCO Finland
Plastic repair of auricle
928.4
323.0
324
*
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
3796.5
323.0
608
*
Q17.5
ICD-10 Finland
Prominent ear
3956.3
323.0
353
*
Q18.8
ICD-10 Finland
Other specified congenital malformations of face and neck
+∞
315.5
296
*
Q13.2
ICD-10 Finland
Other congenital malformations of iris
+∞
239.5
226
*
Q18.1
ICD-10 Finland
Preauricular sinus and cyst
1781.6
167.6
161
*
Q10.5
ICD-10 Finland
Congenital stenosis and stricture of lacrimal duct
555.8
159.8
157
*
Q12.0
ICD-10 Finland
Congenital cataract
+∞
155.9
148
*
ENB50
NOMESCO Finland
Excision of cyst or fistula of thyroglossic duct
767.6
148.7
145
*
Q10.0
ICD-10 Finland
Congenital ptosis
+∞
122.9
117
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
8.7
115.6
263
334
Q14.10
ICD-10 Finland
Congenital retinoschis
+∞
72.2
69
*
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
28.7
63.1
86
31
Q16.1
ICD-10 Finland
Congenital absence, atresia and stricture of auditory canal (external)
+∞
62.8
60
*
Q17.2
ICD-10 Finland
Microtia
+∞
61.7
59
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
56.3
221
547
DAB20
NOMESCO Finland
Closure of preauricular fistula
266.0
51.3
52
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
46.5
915
5766
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
45.3
704
4044
Q14.2
ICD-10 Finland
Congenital malformation of optic disc
+∞
40.7
39
*
ZXA00
NOMESCO Finland
Right side
2.1
39.3
552
3014
Q15.0
ICD-10 Finland
Congenital glaucoma
+∞
37.6
36
*
ZXA10
NOMESCO Finland
Bilateral
2.2
36.5
437
2220
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
36.2
816
5280
Q14.8
ICD-10 Finland
Other congenital malformations of posterior segment of eye
+∞
34.4
33
*
DAD10
NOMESCO Finland
Reconstruction of auricle
341.7
34.0
34
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
13.5
30.5
53
40
Q16.3
ICD-10 Finland
Congenital malformation of ear ossicles
+∞
29.2
28
*
H27.0
ICD-10 Finland
Aphakia
34.1
28.7
37
11
ZXA05
NOMESCO Finland
Left side
1.9
28.5
470
2691
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.1
27.2
342
1757
Q16.0
ICD-10 Finland
Congenital absence of (ear) auricle
+∞
27.1
26
*
H02.4
ICD-10 Finland
Ptosis of eyelid
5.3
26.1
81
157
Q18.9
ICD-10 Finland
Congenital malformation of face and neck, unspecified
+∞
25.0
24
*
Q17.3
ICD-10 Finland
Other misshapen ear
+∞
25.0
24
*
Q18.2
ICD-10 Finland
Other branchial cleft malformations
+∞
25.0
24
*
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
68.1
23.8
27
*
ZXE00
NOMESCO Finland
One hour or less
1.6
23.3
906
6637
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
7.0
23.0
57
83
Q13.0
ICD-10 Finland
Coloboma of iris
+∞
22.9
22
*
CCA20
NOMESCO Finland
Incision of lacrimal punctum or canaliculus
30.3
22.8
30
10
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
14.3
22.6
38
27
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.5
22.4
178
732
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
21.3
217
1011
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
8.2
21.2
47
58
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
5.9
21.0
59
102
S01ED01
ATC
timolol; ophthalmic
4.5
20.8
74
167
UDC00
NOMESCO Finland
Ear microscopy
2.3
20.7
202
922
L02.1
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of neck
7.8
20.5
47
61
Q89.23
ICD-10 Finland
Cyst of the ductus thyreoglossus
40.4
19.5
24
6
Q17.0
ICD-10 Finland
Accessory auricle
+∞
18.8
18
*
Q17.8
ICD-10 Finland
Other specified congenital malformations of ear
+∞
18.8
18
*
CBJ10
NOMESCO Finland
Fascia plate sling or synthetic material for ptosis correction
191.3
18.6
19
*
DFF00
NOMESCO Finland
Pure tone audiometry
2.3
18.5
178
809
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
5.0
18.1
58
118
Q14.18
ICD-10 Finland
Congenital malformation of retina
+∞
17.7
17
*
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
17.7
188
895
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.3
17.7
89
274
7433A
ICD-9 Finland
Congenital anomalies of eye, Congenital cataract and lens anomalies
95.7
17.6
19
*
74439
ICD-8 Finland
Congenital anomalies of eye, Cataracta NUD
181.2
17.5
18
*
H53.0
ICD-10 Finland
Amblyopia ex anopsia
4.6
17.3
60
133
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
8.0
17.0
38
48
Z31.5
ICD-10 Finland
Genetic counselling
2.3
16.8
156
695
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.8
16.3
46
81
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
16.1
354
2197
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.3
15.8
147
656
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
15.8
15.7
25
16
74482
ICD-8 Finland
Congenital anomalies of eye, Ptosis
85.6
15.6
17
*
Q10.30
ICD-10 Finland
Other congenital malformations of eyelid
160.9
15.5
16
*
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
4.3
15.5
57
135
WX110
NOMESCO Finland
Local anesthesy
1.4
15.3
1678
14715
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
15.0
226
1239
H33.1
ICD-10 Finland
Retinoschisis and retinal cysts
12.5
14.9
26
21
S01ED51
ATC
timolol, combinations; ophthalmic
2.6
14.8
105
408
114
Kela drug reimbursment
Glaucoma
2.5
14.3
111
452
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
8.7
14.2
30
35
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
7.7
14.1
32
42
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
5.1
14.1
44
88
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
14.0
516
3647
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.9
14.0
209
1139
ZXB10
NOMESCO Finland
Medial
7.5
13.9
32
43
WX402
NOMESCO Finland
General anaesthesia
1.6
13.8
376
2466
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
13.6
13.7
23
17
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
14.8
13.6
22
15
Q17.9
ICD-10 Finland
Congenital malformation of ear, unspecified
+∞
13.5
13
*
Q13.1
ICD-10 Finland
Absence of iris
+∞
13.5
13
*
DBD30
NOMESCO Finland
Correction of atresia of external auditory canal
140.7
13.5
14
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
16.3
13.4
21
13
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
12.9
13.4
23
18
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
4.5
13.3
46
103
J01DA01
ATC
[U] cefalexin; systemic
1.4
13.3
1296
10991
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
8.6
13.2
28
33
DAB00
NOMESCO Finland
Excision of lesion of auricle
7.9
13.1
29
37
XCK00
NOMESCO Finland
Perimetry
2.3
13.0
118
521
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
12.6
158
806
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
12.6
255
1540
DEE00
NOMESCO Finland
Osseous fixation of hearing aid
130.6
12.4
13
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
12.4
186
1017
CKD60
NOMESCO Finland
Anterior vitrectomy
9.7
12.2
24
25
S01EC01
ATC
acetazolamide; systemic
3.9
12.1
49
128
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
11.5
643
4924
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
4.9
11.1
35
72
S01AX11
ATC
[U] ofloxacin; ophthalmic
2.8
11.0
69
250
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
2.9
10.9
66
235
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
10.9
603
4602
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.0
10.8
62
212
TCG10
NOMESCO Finland
Removal of sutures from cornea
9.6
10.7
21
22
Q67.0
ICD-10 Finland
Facial asymmetry
60.2
10.6
12
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
8.0
10.6
23
29
J01DB01
ATC
cefalexin; oral
1.4
10.5
1855
16958
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.2
10.5
53
167
ZXD20
NOMESCO Finland
Day surgery
1.6
10.4
257
1638
Q14.0
ICD-10 Finland
Congenital malformation of vitreous humour
+∞
10.4
10
*
Q13.4
ICD-10 Finland
Other congenital corneal malformations
+∞
10.4
10
*
Q12.1
ICD-10 Finland
Congenital displaced lens
+∞
10.4
10
*
Q10.2
ICD-10 Finland
Congenital entropion
+∞
10.4
10
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
10.4
137
716
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
6.4
10.3
26
41
UJC01
NOMESCO Finland
Scopy of lower throat
5.5
9.9
28
51
H26.4
ICD-10 Finland
After-cataract
2.2
9.9
100
468
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.3
9.9
48
147
ZZG00
NOMESCO Finland
Graft of cartilage
16.8
9.9
15
9
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
9.8
434
3168
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
5.0
9.7
30
61
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
9.7
288
1927
WX400
NOMESCO Finland
Inhalation anesthesy
2.0
9.4
123
640
CJF10
NOMESCO Finland
Secondary implantation of artificial lens in posterior chamber
100.4
9.4
10
*
H26.00
ICD-10 Finland
Infantile, juvenile and presenile cataract
30.1
9.4
12
*
Q16.9
ICD-10 Finland
Congenital malformation of ear causing impairment of hearing, unspecified
+∞
9.4
9
*
7442B
ICD-9 Finland
Congenital anomalies of ear, face and neck, Other specified anomalies of ear[MICROTIA]
+∞
9.4
9
*
Q16.4
ICD-10 Finland
Other congenital malformations of middle ear
+∞
9.4
9
*
DAW99
NOMESCO Finland
Other operation on auricle
21.8
9.3
13
6
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.2
9.1
91
424
3793A
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]
36.8
9.0
11
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
4.1
8.9
33
81
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
8.9
948
7967
H26.01
ICD-10 Finland
Infantile, juvenile and presenile cataract
24.1
8.9
12
5
DC1AD
NOMESCO Finland
Temporalbone CT
4.3
8.9
31
72
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.8
8.8
35
92
DDA00
NOMESCO Finland
Stapedotomy
6.3
8.8
22
35
S01EX03
ATC
NA
4.3
8.6
30
70
DFF15
NOMESCO Finland
Speech audiometry
2.5
8.6
64
260
WX140
NOMESCO Finland
Parabulbar anesthesy
2.5
8.5
65
264
H44.5
ICD-10 Finland
Degenerated conditions of globe
27.6
8.5
11
*
Q87.09
ICD-10 Finland
Other congenital malformations that mainly affect the appearance of the face
27.6
8.5
11
*
R3120
NOMESCO Finland
Training in mobility skills
20.1
8.5
12
6
4105
FHL
Earlobe reconstruction or plastic
90.3
8.4
9
*
74420
ICD-8 Finland
Congenital anomalies of eye, Buphthalmus (glaucoma)
90.3
8.4
9
*
Q11.1
ICD-10 Finland
Other anophthalmos
+∞
8.3
8
*
7432A
ICD-9 Finland
Congenital anomalies of eye, Buphthalmos[GLAUCOMA CONGENITUM]
+∞
8.3
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
8.3
698
5666
S01EC04
ATC
brinzolamide; ophthalmic
2.8
8.2
49
175
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
8.1
101
519
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
8.1
802
6654
CJD20
NOMESCO Finland
Extracapsular cataract extraction with implantation of artificial lens in posterior chamber
17.2
8.1
12
7
4CJ01
NOMESCO Finland
NA
17.2
8.1
12
7
H27.1
ICD-10 Finland
Dislocation of lens
11.7
8.1
14
12
D18.1
ICD-10 Finland
Lymphangioma, any site
8.9
8.0
16
18
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
22.1
8.0
11
5
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
5.3
8.0
23
44
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.2
8.0
74
336
S01EC03
ATC
dorzolamide; ophthalmic
4.8
7.9
25
53
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
13.1
7.9
13
10
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
7.8
7.9
17
22
Z3226
NOMESCO Finland
Physiotherapist
1.4
7.9
359
2628
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
7.8
167
1026
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
4.9
7.6
23
47
3768
FHL
Eye examination under general anesthesia
25.1
7.6
10
*
H26.2
ICD-10 Finland
Complicated cataract
4.0
7.6
28
70
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.2
7.5
37
117
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.5
7.5
56
228
CBJ99
NOMESCO Finland
Other operation for ptosis
80.3
7.4
8
*
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
13.4
7.4
12
9
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
6.0
7.4
19
32
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
8.4
7.3
15
18
Q87.27
ICD-10 Finland
CHARGE association
+∞
7.3
7
*
Q14.9
ICD-10 Finland
Congenital malformation of posterior segment of eye, unspecified
+∞
7.3
7
*
Q11.2
ICD-10 Finland
Microphthalmos
+∞
7.3
7
*
7436B
ICD-9 Finland
Congenital anomalies of eyelids, lachrymal system and orbit[PTOSIS CONGENITA]
+∞
7.3
7
*
QAA10
NOMESCO Finland
Incision of skin of head or neck
9.4
7.3
14
15
ZXC10
NOMESCO Finland
Use of laser
2.7
7.3
45
166
CHD99
NOMESCO Finland
Other filtering operation
15.8
7.2
11
7
P85
ICPC
Mental retardation
5.4
7.2
20
37
UGC02
NOMESCO Finland
Rigid bronchoscopy
5.4
7.2
20
37
H33.0
ICD-10 Finland
Retinal detachment with retinal break
2.9
7.2
42
148
N02BE01
ATC
paracetamol; systemic, rectal
1.3
7.2
1759
16252
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
7.2
143
862
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.5
7.2
31
89
R51.80
ICD-10 Finland
Headache
1.4
7.1
340
2507
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
7.1
460
3573
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
7.1
406
3091
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.2
7.0
34
107
S01EE01
ATC
latanoprost; ophthalmic
2.2
6.9
67
312
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.8
6.9
41
147
D21.0
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of head, face and neck
5.8
6.9
18
31
WX002
NOMESCO Finland
Sedation and analgesia
1.4
6.9
310
2264
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.9
6.8
93
497
S01EE05
ATC
tafluprost; ophthalmic
2.8
6.8
40
143
ENA32
NOMESCO Finland
Incision of deep pharyngeal infection
9.3
6.8
13
14
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
5.3
6.8
19
36
H18.1
ICD-10 Finland
Bullous keratopathy
40.2
6.8
8
*
ENB99
NOMESCO Finland
Other excision of pharynx and adjacent structures
16.7
6.7
10
6
H52.2
ICD-10 Finland
Astigmatism
2.5
6.7
49
199
R13
ICD-10 Finland
Dysphagia
1.9
6.7
96
523
H57.0
ICD-10 Finland
Anomalies of pupillary function
4.7
6.7
21
45
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
22.6
6.7
9
*
H52.1
ICD-10 Finland
Myopia
1.9
6.7
89
470
ZX114
NOMESCO Finland
Intramuscular
3.0
6.6
36
123
Z3231
NOMESCO Finland
Registered nurse
1.3
6.6
555
4480
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.7
6.6
122
719
Q21.21
ICD-10 Finland
Atrioventricular duct
70.0
6.4
7
*
Q87.03
ICD-10 Finland
Syndrome Goldenhar
70.0
6.4
7
*
3242
FHL
Levator resection
70.0
6.4
7
*
BAA60
NOMESCO Finland
Total thyroidectomy
2.6
6.4
45
177
WX704
NOMESCO Finland
Intubation
1.7
6.4
132
804
SPAT1153
SPAT
Removal of sutures
1.3
6.4
513
4111
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
3.4
6.3
28
83
S01EA03
ATC
apraclonidine; ophthalmic
5.2
6.3
18
35
H03AA01
ATC
levothyroxine sodium; systemic
1.4
6.3
373
2852
3621
FHL
In the aftermath of the dissection
+∞
6.3
6
*
Q10.1
ICD-10 Finland
Congenital ectropion
+∞
6.3
6
*
Q16.2
ICD-10 Finland
Absence of eustachian tube
+∞
6.3
6
*
Q87.8
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
6.3
6
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
26.7
6.2
8
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
6.2
91
501
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.6
6.1
142
897
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.0
1175
10471
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
6.0
105
611

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
139
419
3.44
38.17
1.3
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2419
22544
1.62
14.58
13.2
11.5
mg/l
22.0
21.7
0.18
1911
17199
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
41
115
3.60
12.70
8.8
6.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1111
9237
1.34
12.09
8.4
7.1
mmol/l
1.2
1.2
0.42
947
7894
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1022
8416
1.34
11.77
8.0
6.7
mmol/l
1.2
1.2
0.38
941
7717
(3019550) Sodium [Moles/volume] in Serum or Plasma
2314
21565
1.47
11.70
14.4
12.4
mmol/l
139.6
139.6
0.02
2261
20941
(3023103) Potassium [Moles/volume] in Serum or Plasma
2317
21619
1.46
11.44
14.6
12.5
mmol/l
3.9
3.9
0.30
2260
20944
(40768804) Tissue Pathology biopsy report
963
7907
1.34
11.16
1.9
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1357
11715
1.31
10.95
5.7
4.9
mmol/l
6.4
6.4
0.26
1251
10722
(3013650) Neutrophils [#/volume] in Blood by Automated count
1463
12823
1.30
10.28
8.6
9.1
e9/l
4.1
3.9
1.67
1300
11170
(3024561) Albumin [Mass/volume] in Serum or Plasma
948
7842
1.32
10.20
5.4
5.1
g/l
36.6
36.6
0.17
877
7319
(40761511) CBC panel - Blood by Automated count
2487
23683
1.54
9.66
12.6
10.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
55
218
2.55
9.46
6.9
4.3
u/ml
139.2
93.2
0.25
20
66
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1916
17515
1.31
9.33
4.3
3.9
pmol/l
14.7
14.5
1.62
1746
16108
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1690
15196
1.29
9.32
7.1
6.8
u/l
79.1
79.7
0.16
1598
14325
(3002256) Pathology report gross observation
339
2442
1.44
8.52
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
585
4621
1.34
8.42
4.4
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2172
20331
1.33
8.13
5.1
4.5
mu/l
1.9
2.0
0.37
2028
19048
(42870588) Differential panel, method unspecified - Blood
892
7492
1.28
8.12
6.7
6.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1326
11697
1.26
7.97
6.5
6.5
e9/l
2.0
2.0
0.03
1197
10389
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2425
23115
1.43
7.94
14.0
12.4
umol/l
72.8
71.3
1.27
2425
23106
(3032080) INR in Blood by Coagulation assay
806
6712
1.28
7.79
7.3
7.1
inr
1.1
1.2
0.66
271
2137
(3018010) Neutrophils/100 leukocytes in Blood
1252
10993
1.26
7.76
6.4
6.3
%
55.6
55.4
0.23
1181
10391
(3013707) Erythrocyte sedimentation rate by Westergren method
1712
15589
1.26
7.70
4.0
3.9
mm/h
9.6
9.9
0.32
1599
14512
(3007853) Bacteria identified in Skin by Aerobe culture
349
2575
1.41
7.66
1.8
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1177
10280
1.25
7.58
6.7
6.7
%
0.7
0.7
0.21
1108
9680
(3031040) Bacteria [#/volume] in Urine by Automated count
1574
14210
1.25
7.55
4.5
4.0
e6/l
1289.5
1382.4
0.03
22
171
(3007461) Platelets [#/volume] in Blood
2636
25615
1.76
7.51
19.4
16.8
e9/l
261.2
258.9
1.14
2586
24954
(3013115) Eosinophils [#/volume] in Blood
1317
11671
1.25
7.39
6.7
6.9
e9/l
0.2
0.2
1.05
1180
10306
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
28
88
3.20
7.39
1.3
1.1
%
88.6
93.3
0.43
15
44
(3002030) Lymphocytes/100 leukocytes in Blood
1265
11162
1.25
7.37
6.6
6.5
%
30.1
30.2
0.23
1195
10521
(3024731) MCV [Entitic volume]
2637
25638
1.76
7.34
19.3
16.8
fl
89.7
89.6
0.39
2615
25319
(3035941) MCH [Entitic mass]
2637
25641
1.75
7.30
19.3
16.7
pg
30.0
30.0
0.34
2616
25322
(3000963) Hemoglobin [Mass/volume] in Blood
2638
25656
1.75
7.26
19.6
16.9
g/l
136.0
135.8
0.21
2617
25333
(3026361) Erythrocytes [#/volume] in Blood
2637
25645
1.75
7.24
19.3
16.8
e12/l
4.6
4.6
0.09
2584
24934
(3010813) Leukocytes [#/volume] in Blood
2637
25654
1.74
7.10
19.4
16.9
e9/l
6.9
6.8
1.21
2584
24938
(3037467) Urinalysis macro (dipstick) panel - Urine
1647
15000
1.25
7.07
4.5
4.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1123
9820
1.24
6.97
5.7
5.9
umol/l
12.6
12.0
0.37
1052
9234
(3006504) Eosinophils/100 leukocytes in Blood
1205
10619
1.24
6.96
6.6
6.6
%
2.9
2.8
0.27
1137
9969
(3001604) Monocytes [#/volume] in Blood
1269
11253
1.24
6.90
6.5
6.5
e9/l
0.6
0.6
1.14
1130
9778
(3019069) Monocytes/100 leukocytes in Blood
1211
10687
1.24
6.88
6.8
6.8
%
8.3
8.3
0.09
1142
10094
(3006315) Basophils [#/volume] in Blood
1270
11284
1.23
6.71
6.5
6.5
e9/l
0.0
0.0
0.12
1133
9807
(3018418) pH of Serum or Plasma
634
5207
1.28
6.68
4.6
3.8
ph
7.4
7.4
0.05
129
1018
(3000494) Fungus identified in Specimen by Culture
320
2391
1.38
6.50
1.4
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
33
4.56
6.45
1.1
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2068
19432
1.26
6.23
11.2
9.8
ml/min/173m2
91.8
92.0
0.15
1662
15518
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
623
5155
1.27
6.12
2.2
2.2
u/l
206.6
225.6
0.17
591
4891
(3002385) Erythrocyte distribution width [Ratio]
2098
19775
1.26
5.99
15.6
14.1
%
13.3
13.4
1.60
2052
19376
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
25
84
2.99
5.95
1.4
1.3
%
86.3
89.7
0.18
13
42
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
987
8631
1.22
5.83
2.6
2.4
nmol/l
75.0
72.9
1.47
910
7988
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
209
1481
1.44
5.75
3.8
3.3
pmol/l
4.7
4.7
0.00
185
1314
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1134
10075
1.21
5.67
4.2
4.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
168
1147
1.49
5.59
7.3
6.8
mmol/l
24.5
24.4
0.22
160
1112
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
711
6042
1.24
5.45
2.7
2.6
u/l
57.6
56.1
0.22
664
5598
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
473
3838
1.28
5.39
3.6
3.3
ng/l
1392.8
1097.3
0.38
391
3175
(3013512) EKG study
562
4661
1.26
5.34
3.5
3.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
728
6227
1.23
5.22
3.4
3.1
ng/l
43.2
46.9
0.10
406
3474
(40758558) Short blood count panel - Blood
660
5595
1.24
5.14
5.6
7.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
15
40
3.76
5.09
1.1
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
214
1559
1.40
5.07
6.8
6.2
ph
7.4
7.4
0.64
18
153
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
210
1526
1.41
5.05
6.8
6.3
mmol/l
1.3
1.3
0.06
160
1100
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2417
23299
1.32
5.04
9.5
9.0
u/l
26.5
26.3
0.15
2344
22549
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
215
1571
1.40
5.01
6.8
6.2
kpa
5.2
5.1
1.60
204
1486
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
74
432
1.73
4.74
1.3
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
171
1219
1.43
4.60
7.2
6.7
—
—
—
0
0
(3044889) 12 lead EKG panel
1424
13085
1.18
4.54
3.2
3.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
754
6560
1.21
4.45
2.4
2.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1129
10184
1.18
4.45
9.6
9.1
e9/l
0.0
0.0
0.06
927
8279
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
30
4.01
4.43
1.2
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
182
1322
1.40
4.42
5.5
4.8
ng/l
88.1
76.7
0.89
163
1204
(3042936) Bacteria identified in Isolate by Culture
339
2704
1.29
4.41
2.1
2.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
258
1991
1.33
4.28
6.2
5.9
kpa
5.9
5.8
0.24
251
1937
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
356
2869
1.28
4.27
2.0
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
257
1983
1.33
4.26
6.2
5.9
mmol/l
1.4
1.6
0.52
209
1567
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2028
19264
1.20
4.26
3.4
3.3
mmol/l
1.3
1.2
0.58
1893
18058
(3026008) Bacteria identified in Urine by Culture
671
5798
1.21
4.23
2.9
2.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
236
1803
1.34
4.19
1.4
1.3
u/ml
340.4
238.6
0.33
214
1672
(3022145) Colonoscopy Study observation
269
2099
1.31
4.13
1.3
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2050
19512
1.20
4.12
4.0
3.6
mmol/l
5.7
5.7
0.37
1886
18063
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
585
5005
1.21
4.07
2.4
2.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
595
5114
1.21
3.94
4.4
4.5
%
92.2
92.4
0.06
586
4988
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
210
1593
1.34
3.93
12.0
10.6
mmol/l
24.9
24.6
0.84
210
1587
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
440
3676
1.23
3.85
1.3
1.3
iu/ml
28.7
27.1
0.09
121
1084
(3004789) Transferrin [Mass/volume] in Serum or Plasma
338
2751
1.26
3.74
3.1
2.4
g/l
2.4
2.4
0.39
315
2548
(3015377) Calcium [Moles/volume] in Serum or Plasma
707
6215
1.19
3.62
3.3
3.1
mmol/l
2.4
2.4
0.16
616
5562
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
795
7068
1.18
3.55
3.0
3.4
u/l
29.6
31.5
1.01
752
6740
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
176
1326
1.35
3.47
5.7
6.8
mmol/l
23.7
23.9
0.28
164
1240
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
154
1137
1.38
3.45
3.2
3.6
ng/l
159.6
172.7
0.18
136
1013
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1209
11120
1.16
3.44
3.2
2.9
ug/l
86.2
88.9
0.23
1133
10456
(3024354) Oxygen [Partial pressure] in Venous blood
223
1741
1.31
3.44
5.2
5.7
kpa
5.0
4.8
0.68
217
1690
(40768797) Stomach Pathology biopsy report
317
2587
1.25
3.43
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
796
7095
1.17
3.43
1.9
1.8
pmol/l
95.4
96.7
0.39
430
3866
(3017446) Testosterone [Moles/volume] in Serum or Plasma
210
1631
1.31
3.37
2.1
2.1
nmol/l
11.4
11.8
0.25
185
1434
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
395
3309
1.23
3.37
2.7
2.7
e6/l
1.0
1.2
0.45
235
1816
(3011648) Oxygen content in Venous blood
33
168
1.98
3.33
5.8
9.7
%
12.5
11.4
0.97
33
168
(3022948) Iron [Moles/volume] in Serum or Plasma
363
3019
1.23
3.32
3.2
2.4
umol/l
13.3
14.1
1.29
342
2807
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2106
20214
1.18
3.30
3.8
3.7
mmol/l
4.6
4.7
0.64
1985
19060
(3048689) Calprotectin [Mass/mass] in Stool
414
3493
1.22
3.29
2.6
2.7
ug/g
137.9
114.6
0.50
348
2753
(3018095) Leukocytes [#/volume] in Urine
824
7385
1.17
3.29
4.0
3.6
e6/l
85.0
81.3
0.06
573
4955
(3009508) Creatinine [Moles/volume] in Urine
654
5756
1.18
3.27
3.5
3.5
mmol/l
8.0
8.2
0.46
556
5007
(3003458) Phosphate [Moles/volume] in Serum or Plasma
321
2643
1.24
3.22
9.8
7.1
mmol/l
1.1
1.1
0.61
306
2478
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
376
3150
1.22
3.21
2.8
2.8
e6/l
3.7
3.0
0.55
216
1659
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2092
20084
1.18
3.20
3.8
3.6
mmol/l
1.4
1.5
1.66
1960
18852
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
309
2537
1.25
3.18
3.3
2.5
%
22.3
23.6
0.84
269
2217
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
171
1305
1.33
3.12
1.7
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2121
20405
1.17
3.08
4.1
3.9
mmol/l
2.8
2.8
0.20
1985
19095
(3052592) Norovirus Ag [Presence] in Stool
10
29
3.46
3.04
1.1
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
228
1824
1.27
2.95
10.9
9.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2276
22055
1.19
2.89
13.7
12.4
%
40.3
40.1
0.52
1814
17755
(3002582) Erythrocytes [#/volume] in Urine
679
6059
1.16
2.81
3.6
3.2
e6/l
46.1
65.5
0.52
526
4583
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
108
781
1.40
2.80
9.6
10.6
mg/l
1.4
1.3
0.86
101
747
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1859
17759
1.15
2.78
4.9
4.6
mmol/mol
38.2
38.2
0.12
1728
16701
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
85
590
1.45
2.76
2.4
2.6
ug/l
322.7
404.0
0.25
79
544
(3017509) Phencyclidine [Presence] in Urine
12
42
2.86
2.75
1.7
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
78
2.32
2.74
1.2
1.3
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
23
111
2.08
2.72
1.1
1.1
u/ml
10.8
9.2
—
5
22
(3025941) Bacteria identified in Stool by Culture
178
1396
1.29
2.71
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
711
6383
1.15
2.70
1.4
1.4
u/ml
1.5
1.8
0.35
187
1631
(3012516) Albumin [Mass/volume] in Urine
502
4388
1.18
2.70
3.8
3.4
mg/l
432.0
289.3
0.29
343
2908
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
281
2328
1.23
2.69
2.8
3.5
umol/l
7.9
7.3
0.12
240
1976
(3007164) IgA [Mass/volume] in Serum or Plasma
626
5571
1.16
2.68
1.5
1.5
g/l
2.0
2.1
0.87
388
3405
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
40
235
1.71
2.65
1.5
1.3
nmol/l
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
523
4596
1.17
2.63
4.6
4.1
mg/mmol
11.7
14.0
0.20
351
3030
(3016502) Oxygen saturation in Arterial blood
197
1572
1.27
2.63
10.3
9.1
%
96.2
95.7
0.58
185
1516
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
38
221
1.73
2.61
2.0
2.9
%
12.5
10.9
0.35
25
150
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
80
2.26
2.60
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
403
3470
1.19
2.59
1.3
1.2
u/ml
11.0
10.5
0.05
158
1383
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
249
2046
1.24
2.58
2.2
2.3
u/l
7295.9
7074.5
0.04
106
789
(3002179) Metamyelocytes/100 leukocytes in Blood
197
1576
1.27
2.58
4.5
4.2
%
0.4
0.6
0.68
48
335
(3027315) Oxygen [Partial pressure] in Blood
63
418
1.52
2.57
7.9
4.1
kpa
9.0
9.0
0.01
63
413
(3012501) Base excess in Blood by calculation
63
418
1.52
2.57
7.9
4.1
mmol/l
2.0
2.3
0.27
42
254
(3013290) Carbon dioxide [Partial pressure] in Blood
63
419
1.52
2.54
7.9
4.1
kpa
5.1
4.9
0.61
63
414
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
30
164
1.84
2.53
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
185
1473
1.27
2.52
1.5
1.5
iu/l
18.5
19.7
0.24
146
1187
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
52
332
1.58
2.52
4.6
3.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
73
502
1.47
2.51
6.5
7.0
iu/ml
668.7
306.3
0.37
13
63
(3029937) Albumin [Presence] in Urine by Test strip
640
5733
1.15
2.49
4.1
3.5
estimate
0.0
0.0
1.49
229
2114
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
528
4663
1.16
2.49
2.0
2.2
mg/l
1.1
1.0
0.27
382
3413
(3021440) Promyelocytes/100 leukocytes in Blood
203
1638
1.26
2.48
4.9
4.5
%
0.1
0.1
1.14
55
421
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
45
2.67
2.45
3.5
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
45
2.67
2.45
3.5
2.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
51
2.56
2.44
3.6
6.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
253
2097
1.23
2.43
6.3
7.4
mmol/l
104.6
104.7
0.09
244
2059
(3009214) Lutropin [Units/volume] in Serum or Plasma
145
1125
1.30
2.42
1.7
1.6
u/l
9.1
8.4
0.22
114
879
(3026389) Candida sp identified in Specimen by Organism specific culture
48
304
1.59
2.41
1.6
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
121
916
1.34
2.40
8.9
7.7
kpa
9.2
9.2
0.11
116
870
(1616796) Gas panel - Central venous blood
64
433
1.49
2.40
6.9
3.6
—
—
—
0
0
(4035726)
187
1502
1.26
2.39
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
111
831
1.35
2.38
15.2
12.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1596
15176
1.12
2.35
3.1
3.1
u/l
38.9
39.2
0.05
1511
14423
(3000850) Epithelial cells [#/volume] in Urine
473
4162
1.16
2.34
3.1
2.6
e6/l
10.9
7.2
0.45
406
3671
(3018677) aPTT in Platelet poor plasma by Coagulation assay
337
2887
1.19
2.31
2.9
3.2
s
29.5
29.9
0.54
331
2801
(3035350) Ketones [Presence] in Urine by Test strip
1148
10719
1.12
2.31
3.7
3.3
estimate
0.0
0.0
1.08
224
2108
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
99
732
1.37
2.30
1.9
1.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
72
504
1.44
2.29
7.7
7.5
mmol/l
1.2
1.2
0.36
61
434
(3020779) Urea [Moles/volume] in Serum or Plasma
212
1737
1.24
2.28
11.7
9.4
mmol/l
7.6
7.6
0.06
206
1677
(3003181) Sodium [Moles/volume] in Urine
45
285
1.59
2.28
1.8
1.7
mmol/l
69.8
70.6
0.05
35
242
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
418
3651
1.17
2.27
1.6
1.6
pmol/l
51923533.3
34731543.2
0.18
364
3124
(3030467) Casts [#/volume] in Urine by Automated count
619
5567
1.14
2.27
3.4
3.1
e6/l
0.6
0.3
0.93
468
4141
(3036489) Thrombin time
121
925
1.32
2.26
2.7
3.9
s
21.6
21.8
0.17
106
813
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
72
507
1.43
2.23
1.7
1.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
122
937
1.32
2.22
7.2
7.8
mmol/l
25.2
24.3
1.82
110
874
(3036525) Urea [Moles/time] in 24 hour Urine
5
9
5.56
2.21
5.0
3.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
45
288
1.57
2.19
1.8
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1146
10722
1.12
2.19
5.2
4.5
estimate
0.0
0.0
0.50
235
2173
(3000034) Microalbumin [Mass/volume] in Urine
25
136
1.85
2.17
2.1
3.5
mg/l
33.8
41.1
0.16
19
101
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
39
242
1.62
2.16
1.6
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
234
1951
1.22
2.15
2.0
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
26
144
1.81
2.14
1.0
1.2
u/ml
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
35
212
1.66
2.13
2.1
3.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
40
251
1.60
2.12
1.3
1.3
g/l
0.4
0.4
0.21
31
174
(3028192) IgG subclass 2 [Mass/volume] in Serum
40
251
1.60
2.12
1.3
1.3
g/l
2.9
2.8
0.14
31
177
(3027135) IgG subclass 1 [Mass/volume] in Serum
40
251
1.60
2.12
1.3
1.3
g/l
6.7
6.5
0.12
31
178
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
115
883
1.32
2.11
1.7
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
213
1763
1.23
2.10
10.1
8.5
mmol/l
1.2
0.9
0.55
160
1353
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
237
1983
1.21
2.10
2.0
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
207
1709
1.23
2.10
4.9
4.4
%
0.9
0.9
0.00
56
452
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
40
252
1.60
2.09
1.3
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
42
268
1.58
2.09
2.2
3.0
e9/l
1.2
1.3
0.33
25
164
(3025159) Blasts/100 leukocytes in Blood
190
1557
1.24
2.07
5.1
4.5
%
0.0
0.3
0.75
50
355
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
7
20
3.51
2.05
2.7
3.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
341
2957
1.17
2.04
5.4
5.0
mmol/l
0.8
0.8
0.28
321
2791
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
369
3223
1.17
2.02
3.8
3.3
ng/l
1024.3
462.7
0.51
227
2088
(3036481) Cortisol [Moles/volume] in Serum or Plasma
258
2186
1.20
2.02
2.5
2.2
nmol/l
360.6
372.3
0.40
238
2029
(3005719) IgG [Mass/volume] in Serum or Plasma
216
1801
1.22
2.00
2.9
2.9
g/l
10.3
10.2
0.09
202
1667
(3019225) pH of Specimen
202
1673
1.22
2.00
5.2
3.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1151
10812
1.11
2.00
3.8
3.3
estimate
0.0
0.0
0.80
228
2105
(3004119) Hemoglobin [Mass/volume] in Venous blood
130
1024
1.28
1.99
5.6
4.5
g/l
130.4
130.7
0.05
125
1001
(4062490)
40
256
1.57
1.98
1.3
1.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
25
141
1.78
1.96
1.9
3.2
e6/l
336.4
298.5
0.15
14
93
(3024522) Salmonella sp identified in Specimen by Organism specific culture
39
249
1.57
1.95
1.3
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
105
807
1.31
1.94
5.2
4.4
%
1.3
1.3
0.14
105
802
(3021960) Folate [Moles/volume] in Serum or Plasma
447
3974
1.15
1.93
1.6
1.5
nmol/l
20.8
20.2
0.36
386
3474
(3010421) pH of Blood
70
505
1.40
1.93
7.6
3.9
ph
7.4
7.4
0.13
63
413
(3026782) Osmolality of Urine
439
3899
1.15
1.93
3.2
2.7
mosm/kgh2o
548.9
558.6
0.35
370
3354
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
448
3985
1.15
1.92
4.5
4.3
ug/l
2.2
2.1
0.06
398
3601
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
65
464
1.41
1.91
2.4
2.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
26
150
1.74
1.90
3.5
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
83
618
1.35
1.90
1.8
1.9
iu/l
3.8
4.7
0.67
28
229
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
579
5245
1.13
1.89
2.3
2.3
mg/l
2.8
2.8
0.11
504
4537
(3038177) Helicobacter pylori Ab [Presence] in Serum
58
407
1.43
1.87
1.3
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
236
1.58
1.87
1.6
4.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
237
2009
1.20
1.86
4.3
3.7
%
1.8
1.7
0.41
214
1820
(3022217) INR in Platelet poor plasma by Coagulation assay
209
1751
1.21
1.86
15.2
18.8
inr
1.2
1.2
0.04
45
277
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
138
1107
1.26
1.84
1.6
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
210
1764
1.21
1.82
1.1
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
234
1986
1.19
1.82
1.2
1.2
iu/ml
142.9
155.0
0.19
99
741
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
66
2.13
1.81
1.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
66
2.13
1.81
1.3
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
171
1408
1.23
1.81
5.1
3.5
mmol/l
1.2
1.2
0.82
153
1216
(3026493) Urate [Moles/volume] in Serum or Plasma
504
4538
1.14
1.81
2.8
2.7
umol/l
2226.8
4465.0
0.90
452
4028
(36304419) Bacteria [Presence] in Urine
609
5551
1.12
1.79
3.4
3.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
175
1448
1.22
1.77
10.0
9.2
g/l
123.4
123.2
0.03
165
1397
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
52
362
1.44
1.77
1.7
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
38
248
1.54
1.76
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
66
481
1.38
1.75
1.2
1.3
—
—
—
0
0
(3039000) Anion gap in Blood
48
330
1.46
1.74
9.9
9.8
mmol/l
10.8
11.5
0.60
40
296
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
50
347
1.45
1.73
1.8
1.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
48
331
1.46
1.72
10.0
9.7
mmol/l
104.9
105.3
0.30
40
297
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
30
2.67
1.72
3.4
3.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
110
867
1.28
1.71
4.1
5.6
%
93.5
92.1
0.31
103
814
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
86
656
1.32
1.71
2.0
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
798
7406
1.11
1.69
2.2
2.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
45
308
1.47
1.68
1.4
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
58
417
1.40
1.67
1.2
1.1
iu/ml
31.3
1183.0
0.59
19
122
(3035933) Granulocytes/100 leukocytes in Blood
7
161
0.43
1.66
1.4
1.9
—
—
—
0
0
(4010399)
159
1315
1.22
1.64
1.4
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
326
2871
1.15
1.63
1.8
1.7
nmol/l
1082.5
1183.3
1.26
250
2224
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
64
471
1.37
1.62
8.0
8.1
u/ml
0.3
0.4
0.64
36
261
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
242
2084
1.18
1.62
4.2
3.7
%
31.9
32.1
0.09
175
1509
(3039744) RNA polymerase III Ab [Units/volume] in Serum
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
46
320
1.44
1.60
1.7
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
56
404
1.39
1.59
5.8
6.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
36
239
1.51
1.57
5.4
7.8
mg/l
10.7
10.6
0.04
31
222
(3000093) Morphology [Interpretation] in Blood Narrative
29
183
1.59
1.57
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
886
8295
1.10
1.57
4.0
3.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
27
168
1.61
1.55
2.8
2.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
208
1777
1.18
1.54
10.2
8.4
kpa
5.2
5.1
0.50
197
1702
(3027801) Oxygen [Partial pressure] in Arterial blood
208
1777
1.18
1.54
10.2
8.4
kpa
12.7
12.9
0.24
198
1704
(3015171) Extractable nuclear Ab [Units/volume] in Serum
110
881
1.26
1.53
1.3
1.2
u/ml
0.2
1.0
—
9
74
(3025468) Yersinia sp identified in Specimen by Organism specific culture
37
249
1.49
1.52
1.3
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
541
4945
1.12
1.52
3.6
3.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
146
1.65
1.50
1.0
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
37
250
1.49
1.50
1.3
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
77
591
1.31
1.50
7.3
6.7
%
0.9
0.9
0.04
69
552
(3014111) Lactate [Moles/volume] in Serum or Plasma
191
1625
1.19
1.49
10.4
8.0
mmol/l
1.5
1.4
0.53
185
1541
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
33
218
1.52
1.48
1.2
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
28
178
1.58
1.48
2.7
3.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
65
2.00
1.48
5.8
8.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
37
251
1.48
1.47
1.3
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
166
0.48
1.46
1.5
1.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
26
163
1.60
1.46
1.3
1.3
pmol/l
63.5
258.8
—
9
48
(3004809) Band form neutrophils/100 leukocytes in Blood
41
285
1.45
1.45
2.2
3.3
%
0.9
1.4
0.68
35
236
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
28
2.50
1.45
4.4
9.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
352
3147
1.14
1.43
3.8
3.8
%
21.1
21.0
0.03
159
1342
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
67
508
1.33
1.43
1.8
1.8
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
33
221
1.50
1.41
2.1
3.1
e9/l
0.2
0.2
0.28
23
184
(3020191) Ethanol [Moles/volume] in Serum or Plasma
31
205
1.52
1.40
1.5
1.4
promille
1.3
1.2
0.12
23
161
(3030313) Adrenal Ab [Titer] in Serum
9
40
2.25
1.40
1.4
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
123
1010
1.23
1.40
12.3
10.2
%
94.1
94.0
0.07
123
1004
(3045424) Erythrocytes [Presence] in Urine
46
331
1.40
1.37
1.4
1.4
—
—
—
0
0
(44790047)
42
298
1.42
1.35
1.6
1.8
—
—
—
0
0
(44806118)
42
298
1.42
1.35
1.6
1.8
—
—
—
0
0
(44790048)
42
298
1.42
1.35
1.6
1.8
—
—
—
0
0
(44790049)
42
298
1.42
1.35
1.6
1.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
42
2.15
1.33
1.0
12.8
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
33
224
1.48
1.33
2.1
3.0
e6/l
373.9
544.9
1.85
23
184
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
89
709
1.26
1.33
5.5
4.0
%
51.9
50.7
0.17
89
701
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
39
274
1.43
1.33
1.4
1.5
mmol/l
9.8
12.0
—
6
45
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
76
594
1.29
1.32
7.2
6.6
%
1.6
1.6
0.14
68
553
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
735
6871
1.10
1.32
1.7
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
32
217
1.48
1.30
1.2
1.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
174
1490
1.18
1.29
1.6
1.6
mu/l
371.1
307.5
1.24
159
1327
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
91
1.76
1.29
2.6
1.8
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
165
1408
1.18
1.28
4.7
3.4
e9/l
80.0
71.0
1.43
130
1030
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
44
2.05
1.26
2.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
172
1475
1.18
1.26
2.1
2.5
e9/l
4.1
4.2
0.03
142
1232
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
35
244
1.44
1.25
1.9
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
405
3685
1.12
1.25
1.8
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
61
467
1.31
1.25
1.2
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
19
115
1.66
1.24
2.4
4.2
umol/l
207.4
158.6
0.21
12
65
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1932
18829
1.09
1.24
3.8
3.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
41
295
1.40
1.24
1.2
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
36
2.23
1.24
1.0
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
117
971
1.21
1.23
6.3
5.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
56
1.97
1.22
1.3
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
165
1415
1.18
1.21
2.6
2.5
ml/min/173m2
74.4
74.1
0.04
63
529
(3000492) Spirometry study
246
2176
1.14
1.21
1.3
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
74
585
1.27
1.20
1.9
2.0
ug/l
1.1
1.8
0.39
64
518
(3020891) Body temperature
80
639
1.26
1.20
5.6
4.9
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
23
148
1.56
1.20
1.5
1.6
%
23.8
33.9
0.82
14
95
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
36
255
1.42
1.19
1.3
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
114
947
1.21
1.19
1.8
1.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
38
2.11
1.18
1.3
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
30
206
1.46
1.17
1.7
1.7
%
57.6
56.2
0.06
19
138
(3003338) MCHC [Mass/volume]
2096
20522
1.09
1.15
15.6
14.4
g/l
333.5
333.5
0.02
2084
20352
(40768446) Kidney Pathology biopsy report
18
110
1.64
1.15
2.3
1.9
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
20
2.50
1.15
1.2
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
5
20
2.50
1.15
1.8
1.3
nmol/l
38.1
14.6
—
5
20
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
69
545
1.27
1.14
1.7
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
14
80
1.75
1.12
2.5
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
208
1829
1.15
1.12
2.9
2.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
17
103
1.65
1.12
1.4
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
55
423
1.31
1.12
2.3
2.4
g/l
128.2
132.5
0.69
43
327
(3049717) Cytology report of Urine Cyto stain
61
476
1.29
1.11
3.0
2.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
220
1944
1.14
1.11
5.0
4.6
u/l
243.2
245.5
0.07
212
1851
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
135
1.56
1.11
1.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
161
1393
1.17
1.09
2.4
1.8
g/l
1.4
1.3
0.13
152
1299
(40768443) Skin Pathology biopsy report
96
794
1.22
1.07
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
513
4765
1.09
1.07
4.1
3.4
kg/l
1.0
1.0
0.07
71
696
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
216
1913
1.14
1.06
2.1
2.4
u/l
33.2
63.1
0.62
197
1614
(40765089) Chromosome analysis panel - Blood by G-banded
24
161
1.49
1.06
1.0
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
59
462
1.28
1.06
3.3
4.1
mmol/l
3.7
3.9
1.52
51
435
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
142
1220
1.17
1.05
2.1
2.3
ug/l
7.4
7.3
0.02
115
1090
(3022670) pH of Venous cord blood
7
33
2.12
1.05
1.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
33
2.12
1.05
1.0
2.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
254
1.38
1.04
1.8
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
24
162
1.49
1.04
1.4
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
22
2.27
1.03
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
90
1083
0.83
1.03
1.4
1.5
—
—
—
0
0
(4015189)
7
34
2.06
1.03
2.3
3.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
13
215
0.60
1.02
1.5
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
60
1.84
1.02
1.1
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
106
1.61
1.02
2.5
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
98
817
1.21
1.02
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
229
2043
1.13
1.02
5.0
5.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
48
369
1.31
1.00
1.4
1.5
mmol/l
7.4
6.9
0.52
33
254
(21494890) Protein electrophoresis panel - 24 hour Urine
7
133
0.53
0.98
4.3
2.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
21
308
0.68
0.98
1.5
3.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
212
0.61
0.98
1.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
50
389
1.29
0.96
1.3
1.6
g/l
0.8
0.8
0.19
38
297
(3042733) HLA Ab [Presence] in Serum
16
100
1.60
0.96
5.6
4.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
17
108
1.58
0.96
1.4
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
205
1825
1.13
0.95
2.3
2.8
g/l
0.2
0.2
0.69
200
1719
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
62
497
1.25
0.95
1.1
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
161
1411
1.15
0.95
1.2
1.3
au/ml
38.5
42.8
—
7
57
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
51
1.77
0.94
2.6
6.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
651
6142
1.08
0.94
3.4
2.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
839
7990
1.07
0.94
2.3
2.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
19
125
1.52
0.93
2.7
2.3
u/field
2.1
2.5
0.19
11
65
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
27
2.22
0.93
3.2
2.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
32
234
1.37
0.93
1.4
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
8
142
0.56
0.93
1.0
1.3
—
1.4
—
0
7
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
52
1.73
0.92
2.4
2.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
52
1.73
0.92
1.6
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
91
1080
0.84
0.92
1.4
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
55
1.82
0.92
2.8
6.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
35
261
1.35
0.91
2.0
2.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
23
160
1.44
0.88
1.0
1.2
ratio
1.1
1.1
—
9
68
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
42
1.91
0.88
1.0
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
18
119
1.52
0.88
2.2
2.0
umol/l
113.4
98.2
—
5
24
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
255
2314
1.11
0.88
2.8
2.8
ug/l
0.7
0.7
0.02
150
1386
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
391
3625
1.09
0.87
2.2
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
255
2315
1.11
0.87
1.2
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
48
604
0.79
0.86
1.2
1.4
—
1287.8
—
0
18
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
574
5409
1.08
0.86
2.4
2.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
153
1.44
0.85
1.2
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
153
1.44
0.85
1.2
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
153
1.44
0.85
1.2
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
104
892
1.17
0.83
1.1
1.2
u/ml
0.9
2.5
2.02
54
438
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
95
809
1.18
0.83
2.2
2.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
95
1110
0.85
0.82
1.5
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
141
0.57
0.82
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
112
968
1.16
0.82
1.6
1.6
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
37
284
1.31
0.81
1.9
2.1
mmol/l
1.7
1.7
0.03
37
279
(3009871) Measles virus Ab [Titer] in Serum
12
73
1.65
0.81
1.8
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
12
73
1.65
0.81
2.3
2.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
34
258
1.32
0.81
1.3
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
324
2990
1.09
0.81
2.8
2.7
mmol/l
2.4
2.4
0.00
275
2617
(40767503) Oxygen content in Capillary blood by calculation
47
373
1.26
0.81
2.9
2.6
%
16.3
17.0
0.54
27
197
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
58
1.73
0.79
1.3
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
338
3130
1.09
0.79
1.4
1.4
titre
432.3
514.4
0.39
62
605
(46235168) Fasting glucose [Moles/volume] in Blood
0
26
0.00
0.78
0.0
1.2
—
8.9
—
0
6
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
31
234
1.33
0.77
1.5
1.5
pmol/l
309.7
397.6
0.60
26
180
(3013139) Helicobacter pylori Ag [Presence] in Stool
156
1390
1.13
0.76
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
566
5358
1.07
0.76
4.9
4.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
84
716
1.18
0.75
1.6
1.8
g/l
0.2
0.2
0.12
77
677
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
24
2.08
0.74
1.0
1.2
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
7
38
1.84
0.73
4.0
2.8
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
19
133
1.43
0.73
1.2
1.3
e6/l
3496.3
2302.6
0.43
11
92
(44813793)
29
219
1.33
0.73
1.1
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
43
343
1.26
0.73
1.5
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
26
193
1.35
0.73
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
76
644
1.19
0.73
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
41
326
1.26
0.72
3.1
3.8
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
13
84
1.55
0.71
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
117
1.46
0.71
1.2
1.4
e6/l
22596.3
86069.6
—
8
69
(3020650) Glucose [Presence] in Urine
11
68
1.62
0.71
1.7
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
29
220
1.32
0.71
1.3
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
26
1.92
0.70
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
105
917
1.15
0.70
1.6
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
102
890
1.15
0.69
1.9
3.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
118
1.44
0.69
2.1
3.0
u/ml
1137.3
1197.9
0.05
17
118
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
622
5927
1.06
0.69
2.5
2.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
66
780
0.84
0.69
1.9
1.4
—
—
—
0
0
(4198724)
27
204
1.33
0.68
1.7
2.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
27
1.85
0.68
1.0
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
95
826
1.16
0.68
1.1
1.1
u/ml
4.8
6.5
0.54
57
501
(3037121) Protein [Mass/volume] in Urine
90
780
1.16
0.67
4.4
4.2
g/l
0.2
0.3
0.58
48
403
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
64
756
0.84
0.67
1.9
1.5
u/ml
203.9
218.7
0.23
43
439
(3011841) English Walnut IgE Ab [Units/volume] in Serum
5
91
0.55
0.67
1.0
1.1
u/ml
37.7
8.8
—
5
77
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
54
448
1.21
0.66
1.3
1.4
u/l
17.9
18.3
0.04
46
386
(3008295) Osmolality of Serum or Plasma
29
223
1.30
0.66
2.2
1.7
mosm/kgh2o
288.5
285.2
0.29
23
173
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
58
485
1.20
0.66
4.5
4.6
mmol/l
23.6
24.4
0.86
50
433
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
55
657
0.83
0.65
1.4
1.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
7
44
1.59
0.65
1.3
1.2
%
41.4
58.2
—
7
34
(3045788) Cell count panel - Pleural fluid
15
103
1.46
0.65
1.2
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
37
296
1.25
0.63
2.2
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
30
1.67
0.61
6.2
6.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
2.0
8.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
139
1.37
0.60
1.6
1.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
163
0.67
0.60
1.3
1.5
g/l
0.9
1.0
0.18
11
163
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
52
1.54
0.59
1.0
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
168
1531
1.10
0.59
2.2
2.3
au/ml
17.9
20.6
—
5
107
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
64
1.56
0.58
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
610
5841
1.06
0.58
1.8
1.7
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.1
—
44.7
—
0
8
(4038314)
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
140
1.36
0.58
2.8
4.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
108
961
1.13
0.58
1.4
1.3
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
35
1.72
0.57
4.2
6.6
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
35
1.72
0.57
4.5
7.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
88
773
1.14
0.57
1.1
1.1
u/ml
2.9
3.4
0.13
23
228
(3023511) Choriogonadotropin [Units/volume] in Urine
124
1114
1.12
0.57
1.3
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
36
1.67
0.56
1.5
1.8
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
6
36
1.67
0.56
1.0
1.0
u/ml
44.8
14.5
—
6
28
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
84
737
1.14
0.56
1.6
1.8
g/l
1.1
1.2
0.52
78
697
(3029075) Extractable nuclear Ab panel - Serum
5
86
0.58
0.56
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
11
73
1.51
0.56
1.2
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
51
602
0.84
0.55
1.2
1.4
titre
53.3
81.7
—
6
60
(3024891) Influenza virus A+B Ag [Presence] in Specimen
84
738
1.14
0.55
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
90
1.45
0.55
1.3
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
60
514
1.17
0.55
1.9
2.1
mg/l
10.4
10.6
0.10
53
483
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
40
330
1.22
0.54
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
521
4978
1.06
0.54
1.6
1.6
mmol/l
1.4
1.4
0.40
455
4315
(3000919) Neutrophils/100 leukocytes in Pleural fluid
6
38
1.58
0.54
1.3
1.1
%
55.0
33.0
—
6
32
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
157
1435
1.10
0.53
2.0
1.9
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
39
1.54
0.53
1.0
1.2
%
3.0
3.1
—
6
31
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
47
396
1.19
0.52
1.7
1.7
mmol/l
7.6
7.3
0.36
29
243
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
361
3417
1.06
0.52
1.7
1.8
%
1.4
1.4
0.26
320
3053
(4034850)
69
602
1.15
0.51
5.9
9.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
15
109
1.38
0.50
1.3
1.9
nmol/l
0.7
1.3
—
9
87
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
28
224
1.25
0.50
3.5
1.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
41
1.46
0.50
2.5
3.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
89
792
1.13
0.50
1.1
1.1
u/ml
1.1
1.2
0.12
46
413
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.1
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.1
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.1
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.1
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
136
1.33
0.49
2.6
1.7
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
46
1.52
0.48
1.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
93
1.40
0.48
2.9
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
119
1.35
0.48
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
123
1349
0.91
0.47
1.4
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
310
2932
1.06
0.47
2.1
2.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
28
227
1.24
0.46
1.0
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
84
0.59
0.45
2.2
1.3
—
64.4
—
0
9
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
124
1355
0.91
0.45
1.4
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
72
638
1.13
0.45
2.1
2.8
umol/l
4.4
6.2
1.55
52
490
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
124
1354
0.91
0.44
1.4
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
12
86
1.40
0.44
1.3
1.4
u/l
10.7
13.9
1.16
12
81
(1761482) Bacteria [#/volume] in Urine by Culture
44
376
1.17
0.44
4.7
3.8
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
124
1352
0.91
0.43
1.4
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
163
0.73
0.43
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
258
2434
1.07
0.43
1.5
1.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
22
175
1.26
0.43
1.0
1.2
u/ml
5.4
22.3
0.52
15
121
(3029396) Erythrocyte agglutination [Presence] in Blood
9
130
0.69
0.43
2.2
3.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
104
1.35
0.43
1.1
1.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
5
31
1.61
0.43
1.2
1.2
—
226.4
—
0
5
(3019832) Treponema pallidum Ab [Presence] in Serum
506
4868
1.05
0.42
1.8
1.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
32
1.56
0.42
1.2
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
32
1.56
0.42
1.2
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
57
1.40
0.42
3.5
2.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
25
203
1.23
0.42
3.2
4.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
149
1.28
0.41
1.0
1.1
miu/ml
1548.7
1474.7
0.11
19
149
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
217
0.78
0.41
1.4
1.6
titre
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
33
1.52
0.41
2.6
1.8
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
6.5
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.6
—
350.9
—
0
16
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
78
700
1.12
0.41
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
43
370
1.16
0.40
1.6
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
96
872
1.10
0.40
3.4
3.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
79
1.39
0.40
1.3
2.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
293
0.82
0.40
5.0
3.5
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
5
34
1.47
0.40
2.8
7.4
ug/min
91.8
28.6
—
5
25
(4024509)
19
150
1.27
0.40
1.3
1.4
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
18
0.00
0.40
0.0
1.3
—
8.9
—
0
9
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
432
0.85
0.39
1.6
1.9
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
61
1.31
0.39
1.3
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
8
61
1.31
0.39
1.3
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
62
550
1.13
0.39
1.4
1.5
nmol/l
0.3
0.4
0.27
51
458
(3014891) Appearance of Pleural fluid
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
241
2279
1.06
0.39
1.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
146
1357
1.08
0.38
2.8
4.1
ug/l
11.1
19.8
0.49
111
1069
(3024263) Appearance of Synovial fluid
11
80
1.38
0.38
1.9
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
11
80
1.38
0.38
1.6
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
61
542
1.13
0.38
1.4
1.4
ug/g
255.3
311.4
0.90
27
291
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(44806420)
5
36
1.39
0.38
2.2
2.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
68
1.32
0.37
1.0
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
68
1.32
0.37
1.0
1.9
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
13
98
1.33
0.37
1.5
1.2
g/l
0.3
0.3
—
7
82
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
49
430
1.14
0.37
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
49
430
1.14
0.37
1.3
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
20
161
1.24
0.37
1.4
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
134
1.27
0.36
2.6
2.6
%
33.3
44.4
—
8
40
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
70
1.29
0.36
1.0
1.9
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
30
253
1.19
0.36
1.6
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
81
1.36
0.36
1.2
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
81
1.36
0.36
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
76
0.66
0.35
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
88
803
1.10
0.35
1.2
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
21
171
1.23
0.35
1.5
1.7
umol/l
24.7
23.8
0.05
21
161
(3037556) Urate [Mass/volume] in Serum or Plasma
6
42
1.43
0.35
1.2
1.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
18
144
1.25
0.35
1.1
1.1
—
34.4
—
0
8
(3011897) Casein IgE Ab [Units/volume] in Serum
15
117
1.28
0.35
1.8
1.5
u/ml
1.2
7.4
—
6
27
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
22
181
1.22
0.34
1.9
2.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
63
566
1.12
0.34
2.2
3.2
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
18
145
1.24
0.33
1.4
1.4
%
71.7
74.0
0.39
18
139
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
39
340
1.15
0.33
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
131
1222
1.08
0.33
1.9
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
50
444
1.13
0.33
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
182
1.21
0.33
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
183
1.20
0.31
1.3
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
14
110
1.27
0.31
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
34
295
1.15
0.31
1.3
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
212
2015
1.06
0.31
4.5
3.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
7
52
1.35
0.31
1.3
1.3
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
7
54
1.30
0.30
1.3
2.4
nmol/l
1.8
3.2
—
7
49
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
75
1.33
0.30
1.8
2.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
93
1.29
0.30
1.2
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
45
401
1.12
0.29
1.1
1.3
u/ml
2.1
4.6
1.58
15
132
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
107
0.75
0.29
1.0
1.4
—
—
—
0
0
(4146454)
17
139
1.22
0.29
2.8
2.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
72
661
1.09
0.28
1.1
1.2
—
—
—
0
0
(4094501)
37
417
0.89
0.27
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
33
290
1.14
0.27
1.5
1.2
u/ml
1.0
3.5
1.55
16
139
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
79
853
0.92
0.26
2.1
2.0
u/l
37.7
39.4
0.31
71
786
(3016650) Hepatitis A virus Ab [Presence] in Serum
38
426
0.89
0.26
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
67
728
0.92
0.26
2.6
2.0
g/l
1.4
1.4
0.06
53
639
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
72
0.69
0.26
1.0
1.0
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
17
141
1.21
0.26
1.4
1.4
mu/l
735.3
384.8
1.11
17
135
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
160
0.81
0.26
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
50
453
1.11
0.26
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
216
1.16
0.25
2.4
2.8
e6/l
716.7
842.4
—
7
69
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
74
685
1.08
0.25
1.8
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
193
2016
0.95
0.24
1.7
2.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
84
0.71
0.24
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
132
1251
1.06
0.24
1.3
1.3
miu/ml
205.6
227.7
0.29
57
621
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
68
629
1.08
0.23
1.6
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
84
784
1.07
0.23
1.7
1.6
iu/ml
0.2
0.1
0.18
13
153
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
179
1712
1.05
0.23
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
28
247
1.13
0.22
1.1
1.1
u/ml
1.5
2.5
—
6
46
(3028433) Virus identified in Specimen by Culture
11
88
1.25
0.22
1.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
31
276
1.12
0.22
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
262
2709
0.96
0.22
1.5
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
20
231
0.86
0.22
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
159
1520
1.05
0.21
1.4
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
107
1.22
0.21
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
163
1.17
0.21
2.6
2.4
—
—
—
0
0
(40758358) Immune stain study
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
129
1227
1.05
0.21
3.0
2.7
g/l
67.4
67.0
0.24
116
1140
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
43
1.16
0.21
2.6
1.9
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
58
538
1.08
0.20
1.3
2.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
49
1.22
0.20
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
768
7557
1.02
0.20
1.6
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
133
0.83
0.19
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
153
1467
1.05
0.19
4.3
3.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
17
146
1.17
0.19
1.1
1.2
—
67.5
—
0
15
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
122
0.82
0.19
1.1
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
52
1.15
0.19
1.2
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
16
137
1.17
0.18
1.1
1.1
—
24.9
—
0
8
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
81
1.24
0.18
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
59
550
1.07
0.18
1.1
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
13
109
1.19
0.18
1.1
1.8
nmol/l
5.4
3.9
0.13
13
83
(21494755) Public health laboratory ask at order entry panel
294
2860
1.03
0.18
1.3
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
75
706
1.06
0.18
1.1
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
42
386
1.09
0.18
2.3
2.7
ug/min
82.8
117.7
0.23
24
253
(3037756) Immunofixation for Serum or Plasma
29
261
1.11
0.18
1.6
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
24
269
0.89
0.18
1.5
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
11
91
1.21
0.17
3.1
2.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
22
195
1.13
0.17
2.0
2.0
mg/l
23.2
23.6
—
10
58
(3002523) Influenza virus A Ag [Presence] in Specimen
59
552
1.07
0.17
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
46
426
1.08
0.17
1.5
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
199
2054
0.97
0.17
1.7
2.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
105
1099
0.95
0.16
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
72
1.11
0.16
2.3
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
28
254
1.10
0.16
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
199
2051
0.97
0.16
1.7
2.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
65
613
1.06
0.16
1.8
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
45
483
0.93
0.15
1.3
1.2
u/ml
9.3
38.1
—
9
43
(3017704) Immunofixation for Urine
6
79
0.76
0.15
1.7
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
119
0.84
0.15
2.2
2.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
119
0.84
0.15
2.2
2.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
139
1340
1.04
0.15
2.9
2.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
102
1.18
0.15
1.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
26
286
0.91
0.15
1.5
2.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
81
1.11
0.15
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
198
2037
0.97
0.14
1.7
2.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
170
1753
0.97
0.14
1.4
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
25
227
1.10
0.14
1.2
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
10
84
1.19
0.14
1.2
1.5
—
9.5
—
0
9
(3024471) HLA-A [Type]
12
103
1.17
0.13
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
170
0.88
0.13
1.9
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
137
1416
0.97
0.13
1.6
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
29
315
0.92
0.13
3.5
3.1
u/ml
6.8
21.1
0.52
29
281
(42529406) Shigella sp [Presence] in Stool by Culture
75
715
1.05
0.13
1.1
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
481
1.06
0.13
3.7
2.2
g/l
10.2
10.3
0.03
37
418
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
22
242
0.91
0.13
1.2
1.2
mg/l
22.5
39.1
4.59
15
195
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
87
907
0.96
0.13
1.5
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
40
374
1.07
0.13
2.6
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
142
1.13
0.12
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
41
437
0.94
0.12
1.4
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
31
287
1.08
0.12
1.0
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
67
639
1.05
0.12
1.3
2.1
mg/l
387.4
464.0
2.16
62
606
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
18
162
1.11
0.11
1.0
1.1
u/l
0.9
1.0
—
7
76
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
95
1.16
0.11
1.3
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
28
302
0.93
0.11
1.0
1.1
g/l
1.5
1.5
0.13
28
269
(3000475) Leukocytes [#/volume] in Synovial fluid
41
386
1.06
0.11
1.7
1.7
e6/l
18959.3
11858.7
0.34
26
287
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
14
124
1.13
0.11
2.6
1.7
mg/l
3.1
3.5
0.36
14
119
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
105
1085
0.97
0.11
1.4
1.7
mg/l
3.3
4.4
0.72
70
727
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
332
0.93
0.11
1.4
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
113
1095
1.03
0.10
1.5
1.5
—
—
—
0
0
(3036603) Volume of Urine
13
115
1.13
0.10
1.3
1.5
—
1963.9
—
0
17
(4281824)
19
173
1.10
0.10
1.1
1.2
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
16
144
1.11
0.10
1.3
1.0
mmol/l
19.9
19.3
0.28
16
136
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
48
456
1.05
0.10
3.0
2.3
g/l
0.7
0.9
0.13
36
410
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
251
1.08
0.10
1.6
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
158
1618
0.97
0.10
1.6
2.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
44
1.14
0.10
1.0
1.7
—
—
—
0
0
(3006598) pH of Arterial cord blood
15
136
1.10
0.08
1.0
1.0
—
—
—
0
0
(4133840)
6
58
1.03
0.08
1.5
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
38
399
0.95
0.08
1.2
1.3
u/ml
2.9
4.7
1.04
14
170
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
145
1480
0.98
0.07
1.4
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
71
0.84
0.07
1.8
2.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
39
372
1.05
0.07
1.7
1.5
—
—
—
0
0
(4306422)
40
382
1.05
0.07
1.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
75
1.07
0.07
1.0
1.9
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
8
76
1.05
0.07
1.1
1.2
u/l
10.6
11.5
—
8
68
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
25
235
1.06
0.07
1.1
1.1
iu/ml
10.4
10.1
—
5
53
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
83
0.84
0.07
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
44
422
1.04
0.07
3.6
3.4
mg/l
20.2
23.8
0.43
30
253
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
96
984
0.97
0.07
1.5
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
85
1.06
0.07
1.0
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
33
314
1.05
0.07
1.8
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
22
206
1.07
0.07
2.4
3.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
91
0.88
0.06
1.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
8
93
0.86
0.06
1.5
2.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
27
285
0.95
0.06
1.3
1.2
u/ml
1.0
11.6
1.19
12
122
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
43
413
1.04
0.06
3.2
2.2
g/l
40.4
38.2
2.12
32
364
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
36
344
1.05
0.06
1.3
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
92
942
0.98
0.06
3.1
2.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
102
0.88
0.06
1.1
1.5
nmol/l
134.2
136.0
—
9
102
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
28
266
1.05
0.06
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
22
207
1.06
0.06
1.1
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
140
1424
0.98
0.06
2.1
3.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
172
0.93
0.06
1.3
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
131
0.92
0.05
1.3
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
51
494
1.03
0.05
1.6
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
272
2748
0.99
0.05
1.8
1.9
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
151
0.93
0.05
1.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
55
566
0.97
0.05
1.3
1.2
u/ml
3.0
11.9
—
7
91
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
161
0.93
0.05
1.4
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
59
575
1.03
0.04
1.3
2.3
e6/l
10.4
21.8
0.73
42
434
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
150
0.93
0.04
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
174
1720
1.01
0.04
1.4
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
59
576
1.02
0.04
1.4
2.3
e6/l
1109.8
7658.1
0.50
45
454
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
170
1.06
0.04
1.2
1.2
—
—
—
0
0
(4027681)
19
200
0.95
0.03
1.4
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
63
643
0.98
0.03
2.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
189
1906
0.99
0.03
1.7
2.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
19
199
0.95
0.03
21.8
20.4
nmol/l
1201.8
1429.8
0.79
19
193
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
10
108
0.93
0.03
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
90
912
0.99
0.02
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
405
4031
1.01
0.02
1.6
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
148
0.95
0.02
1.3
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
15
142
1.06
0.02
1.1
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
15
158
0.95
0.02
2.5
3.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
55
560
0.98
0.02
1.3
1.2
u/ml
2.2
2.9
—
5
60
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
19
198
0.96
0.02
16.3
14.2
nmol/l
680.6
810.4
0.75
19
190
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
24
232
1.03
0.02
2.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
93
1.08
0.02
1.0
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
521
1.02
0.02
3.5
2.1
g/l
6.6
7.4
2.87
35
409
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
521
1.02
0.02
3.5
2.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
113
1.06
0.01
2.0
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
40
408
0.98
0.01
3.2
2.3
g/l
0.0
0.0
0.26
34
382
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
17
163
1.04
0.01
1.1
1.4
nmol/l
1.5
1.5
0.01
17
148
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
207
0.97
0.01
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
51
516
0.99
0.00
2.9
3.6
u/ml
2515.5
2800.5
0.04
45
437
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
494
1.01
0.00
3.7
2.2
g/l
2.8
3.1
2.81
34
395
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
52
514
1.01
0.00
1.0
1.1
u/ml
0.5
0.5
0.01
12
155
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
114
1134
1.01
0.00
1.9
2.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
202
0.99
0.00
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
184
0.98
0.00
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
184
0.98
0.00
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
184
0.98
0.00
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
184
0.98
0.00
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
184
0.98
0.00
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
41
409
1.00
0.00
1.1
1.1
—
—
—
0
0
(4268621)
27
270
1.00
0.00
2.1
2.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
37
375
0.99
0.00
3.2
2.3
g/l
0.0
0.0
0.00
32
350
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
45
445
1.01
0.00
1.2
1.1
u/ml
2.7
2.4
0.12
19
208
(40768806) Pleura Pathology biopsy report
12
121
0.99
0.00
1.2
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
38
377
1.01
0.00
3.2
2.3
g/l
0.0
0.0
0.00
32
351
(3014051) Protein [Presence] in Urine by Test strip
48
481
1.00
0.00
1.8
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
29
292
0.99
0.00
1.8
2.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
61
606
1.01
0.00
1.1
1.1
u/ml
4.5
5.6
0.22
25
264
(3017315) Amylase [Enzymatic activity/volume] in Urine
10
103
0.97
0.00
1.4
1.3
u/l
163.5
397.9
—
10
90
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
455
4551
1.00
0.00
1.5
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
25
249
1.00
0.00
1.1
1.1
—
—
—
0
0
(4211845)
11
105
1.05
0.00
3.1
2.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
56
562
1.00
0.00
1.4
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
61
615
0.99
0.00
2.0
1.6
u/ml
90.0
106.5
0.67
11
100
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
130
1304
1.00
0.00
1.6
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
56
560
1.00
0.00
1.1
1.1
u/ml
4.1
6.9
0.89
26
260
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
125
1.04
0.00
2.1
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
125
1.04
0.00
1.2
1.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
170
1.00
0.00
1.0
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
13
132
0.98
0.00
1.6
2.5
ug/l
21.8
264.5
0.69
13
116
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
132
0.98
0.00
1.5
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
215
0.98
0.00
1.3
1.3
u/ml
1.2
0.7
0.24
11
73
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
41
414
0.99
0.00
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
109
1.01
0.00
1.0
1.1
iu/ml
327.9
219.1
0.24
11
109
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
520
1.00
0.00
3.6
2.1
g/l
4.1
3.7
0.33
34
387
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
119
1.01
0.00
1.1
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
378
1.01
0.00
5.4
3.4
mg/l
63.3
64.3
0.01
25
299
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
38
378
1.01
0.00
5.4
3.4
mg/l
46.2
40.4
0.10
25
300
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
57
575
0.99
0.00
1.2
2.1
mmol/l
3.8
3.6
0.59
51
543
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
185
0.97
0.00
1.2
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
15
153
0.98
0.00
1.5
1.3
e6/l
17324.0
80041.1
—
10
104
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
9
97
0.93
0.00
1.1
1.1
u/l
206.3
82.3
—
9
85
(3001729) Color of Synovial fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
6
60
1.00
0.00
5.3
4.9
mmol/l
1.2
1.2
—
6
55
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
67
0.90
0.00
1.2
1.0
—
—
—
0
0
(3038702) Sodium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
6.3
—
138.3
—
0
7
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
65
0.92
0.00
2.0
2.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
70
1.00
0.00
5.3
2.9
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
16.8
—
0
6
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.3
—
0.3
—
0
6
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
72
0.97
0.00
3.0
2.9
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
9
96
0.94
0.00
3.9
2.7
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
67
0.90
0.00
1.2
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.3
—
0.1
—
0
8
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
9
94
0.96
0.00
1.1
1.1
u/l
15.4
16.4
—
9
81
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
86
0.93
0.00
2.1
4.1
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
133.0
—
0
5
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
50
1.00
0.00
4.8
5.7
—
—
—
0
0
(3017497) Pine Nut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.6
—
0
7
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
9
96
0.94
0.00
7.8
5.4
—
—
—
0
0
(3004982) Buprenorphine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
1.9
—
0
5
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
10.3
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2.6
—
0
5
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
8
0.00
0.00
0.0
1.1
—
8.0
—
0
8
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
67
0.90
0.00
1.2
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
56
0.89
0.00
1.0
1.4
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
7.8
—
97.3
—
0
6

Mortality – FinRegistry

Association

Association between endpoint Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK and mortality.

Females

Parameter HR [95% CI] p-value
Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK 1.228 [1.05, 1.43] 0.01
Birth year 0.989 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 596 out of 19221 females with Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK died.

Males

Parameter HR [95% CI] p-value
Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK 1.217 [1.07, 1.39] 0.003
Birth year 0.989 [0.98, 1.0] 0.014

During the follow-up period (1.1.1998 — 31.12.2019), 742 out of 18380 males with Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK died.

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK.

N-year risk Females Males
1 0.12% 0.234%
5 0.592% 1.33%
10 1.52% 3.435%
15 2.831% 6.677%
20 4.722% 12.141%

Relationships between endpoints

Index endpoint: Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK – Congenital malformations of eye, ear, face and neck

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data